Drug-话题@MedSci

#Drug#

153篇内容 | 3673人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1862276, encodeId=a5af18622e657, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Safety：人们对患者病历中口头风险描述的理解, objectType=article, longId=111327, objectId=030a11132ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=030a11132ecd, replyNumber=0, likeNumber=90, createdTime=2018-07-28, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=030a11132ecd, moduleTitle=Drug Safety：人们对患者病历中口头风险描述的理解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=030a11132ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862277, encodeId=761718622e75c, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Safety：对药物不良事件检测的案例交叉(CCO)研究设计的评价, objectType=article, longId=111328, objectId=9de5111328cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9de5111328cb, replyNumber=0, likeNumber=56, createdTime=2018-04-24, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9de5111328cb, moduleTitle=Drug Safety：对药物不良事件检测的案例交叉(CCO)研究设计的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9de5111328cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862257, encodeId=5140186225e59, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=J Psychoactive Drugs：神奇蘑菇真是神奇！治疗精神类疾病效果确实是好, objectType=article, longId=105247, objectId=1fff10524ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fff10524ed3, replyNumber=0, likeNumber=89, createdTime=2017-10-03, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fff10524ed3, moduleTitle=J Psychoactive Drugs：神奇蘑菇真是神奇！治疗精神类疾病效果确实是好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fff10524ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862246, encodeId=4f49186224657, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=NAT REV DRUG DISCOV：对著名制药企业研发投入的十年统计, objectType=article, longId=100264, objectId=f46810026402, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f46810026402, replyNumber=0, likeNumber=59, createdTime=2017-06-05, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f46810026402, moduleTitle=NAT REV DRUG DISCOV：对著名制药企业研发投入的十年统计, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f46810026402)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862240, encodeId=0ab11862240a6, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Adv Drug Deliv Rev：核酸突变分析方法抉择: PCR、杂交、NGS？, objectType=article, longId=80705, objectId=dae880e053d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dae880e053d, replyNumber=0, likeNumber=70, createdTime=2017-08-18, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dae880e053d, moduleTitle=Adv Drug Deliv Rev：核酸突变分析方法抉择: PCR、杂交、NGS？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dae880e053d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862258, encodeId=4968186225886, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Saf：急性心梗/IS患者：强效缓释阿片类药物会引发缺血性心脑血管事件？, objectType=article, longId=105451, objectId=1c80105451f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c80105451f6, replyNumber=0, likeNumber=0, createdTime=2017-11-10, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c80105451f6, moduleTitle=Drug Saf：急性心梗/IS患者：强效缓释阿片类药物会引发缺血性心脑血管事件？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c80105451f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862249, encodeId=b83d186224915, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Int J Drug Policy：芬太尼，怕上瘾，却又躲不过……, objectType=article, longId=101323, objectId=2fb0101323e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fb0101323e1, replyNumber=0, likeNumber=75, createdTime=2017-06-26, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fb0101323e1, moduleTitle=Int J Drug Policy：芬太尼，怕上瘾，却又躲不过……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fb0101323e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862261, encodeId=bccb186226174, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Alcohol Depen：超强效大麻浓缩物使用潜在增长的担忧, objectType=article, longId=106393, objectId=07b7106393d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07b7106393d5, replyNumber=0, likeNumber=66, createdTime=2018-02-09, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07b7106393d5, moduleTitle=Drug Alcohol Depen：超强效大麻浓缩物使用潜在增长的担忧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07b7106393d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862248, encodeId=98ea186224857, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Saf：警示！因ADR而造成的住院在老年人群中普遍发生, objectType=article, longId=100965, objectId=1bf3100965c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf3100965c2, replyNumber=0, likeNumber=52, createdTime=2018-02-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf3100965c2, moduleTitle=Drug Saf：警示！因ADR而造成的住院在老年人群中普遍发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf3100965c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862244, encodeId=2860186224401, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=NAT REV DRUG DISCOV：开发下一代抗体-药物偶联物（ADC）的策略和挑战, objectType=article, longId=97299, objectId=9cb69e299a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cb69e299a7, replyNumber=0, likeNumber=0, createdTime=2017-07-15, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cb69e299a7, moduleTitle=NAT REV DRUG DISCOV：开发下一代抗体-药物偶联物（ADC）的策略和挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cb69e299a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862241, encodeId=b6e9186224150, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=NAT REV DRUG DISCOV：耳聋治疗药物进入临床试验, objectType=article, longId=82507, objectId=ed668250e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed668250e5a, replyNumber=0, likeNumber=85, createdTime=2017-09-04, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed668250e5a, moduleTitle=NAT REV DRUG DISCOV：耳聋治疗药物进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed668250e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862238, encodeId=13da186223879, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Clin Cancer Drugs：靶向特殊通路或可有效治疗前列腺癌, objectType=article, longId=70646, objectId=7e30e064671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e30e064671, replyNumber=0, likeNumber=74, createdTime=2017-05-10, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e30e064671, moduleTitle=Clin Cancer Drugs：靶向特殊通路或可有效治疗前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e30e064671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862239, encodeId=72a81862239c0, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Saf：妊娠期母亲药物暴露对新生儿的影响：戒断反应和残余药效, objectType=article, longId=73067, objectId=a907e306790, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a907e306790, replyNumber=0, likeNumber=127, createdTime=2017-01-06, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a907e306790, moduleTitle=Drug Saf：妊娠期母亲药物暴露对新生儿的影响：戒断反应和残余药效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a907e306790)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862237, encodeId=79e0186223e78, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=International Journal of Drug Policy：通过经济激励措施推动烟草行业变革, objectType=article, longId=63673, objectId=63b4636e3a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63b4636e3a2, replyNumber=0, likeNumber=52, createdTime=2016-08-14, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63b4636e3a2, moduleTitle=International Journal of Drug Policy：通过经济激励措施推动烟草行业变革, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63b4636e3a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862235, encodeId=fc0e186223578, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：第二代抗精神病药物的肺炎风险对比, objectType=article, longId=58052, objectId=b3fc580522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3fc580522f, replyNumber=0, likeNumber=62, createdTime=2015-11-10, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3fc580522f, moduleTitle=Pharmacoepidemiol Drug Saf：第二代抗精神病药物的肺炎风险对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3fc580522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862233, encodeId=6361186223301, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：FDA和EMA重点审查药品批准的差异性, objectType=article, longId=51415, objectId=36325141535, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36325141535, replyNumber=0, likeNumber=0, createdTime=2015-09-15, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36325141535, moduleTitle=Pharmacoepidemiol Drug Saf：FDA和EMA重点审查药品批准的差异性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36325141535)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862232, encodeId=b04d1862232fc, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Invest New Drugs：dacomitinib(pan-HER 抑制剂)用于晚期头颈部鳞状细胞癌的药代动力学评价, objectType=article, longId=50462, objectId=d8575046299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8575046299, replyNumber=0, likeNumber=64, createdTime=2015-09-22, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8575046299, moduleTitle=Invest New Drugs：dacomitinib(pan-HER 抑制剂)用于晚期头颈部鳞状细胞癌的药代动力学评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8575046299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862236, encodeId=79091862236c1, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Des Devel Ther：来曲唑结合促性腺激素适合克罗米芬(CC)抵抗的多囊卵巢生育障碍患者, objectType=article, longId=60618, objectId=8dd46061824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dd46061824, replyNumber=0, likeNumber=60, createdTime=2016-11-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dd46061824, moduleTitle=Drug Des Devel Ther：来曲唑结合促性腺激素适合克罗米芬(CC)抵抗的多囊卵巢生育障碍患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dd46061824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862234, encodeId=dda21862234fd, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Am J Cardiovasc Drugs：长期抗高血压治疗与卒中预防：荟萃分析, objectType=article, longId=55118, objectId=207555118c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=207555118c4, replyNumber=0, likeNumber=60, createdTime=2016-01-12, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=207555118c4, moduleTitle=Am J Cardiovasc Drugs：长期抗高血压治疗与卒中预防：荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=207555118c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862229, encodeId=a35818622299c, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Nature Reviews Drug Discovery：药商面临巨大挑战：如何提高研发产能？, objectType=article, longId=48347, objectId=5b6f4834e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b6f4834e9e, replyNumber=0, likeNumber=49, createdTime=2016-01-13, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b6f4834e9e, moduleTitle=Nature Reviews Drug Discovery：药商面临巨大挑战：如何提高研发产能？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b6f4834e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Drug

2020-05-29

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Safety：人们对患者病历中口头风险描述的理解

2018-07-28

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Safety：对药物不良事件检测的案例交叉(CCO)研究设计的评价

2018-04-24

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

J Psychoactive Drugs：神奇蘑菇真是神奇！治疗精神类疾病效果确实是好

2017-10-03

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

NAT REV DRUG DISCOV：对著名制药企业研发投入的十年统计

2017-06-05

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Adv Drug Deliv Rev：核酸突变分析方法抉择: PCR、杂交、NGS？

2017-08-18

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Saf：急性心梗/IS患者：强效缓释阿片类药物会引发缺血性心脑血管事件？

2017-11-10

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Int J Drug Policy：芬太尼，怕上瘾，却又躲不过……

2017-06-26

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Alcohol Depen：超强效大麻浓缩物使用潜在增长的担忧

2018-02-09

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Saf：警示！因ADR而造成的住院在老年人群中普遍发生

2018-02-08

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

NAT REV DRUG DISCOV：开发下一代抗体-药物偶联物（ADC）的策略和挑战

2017-07-15

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

NAT REV DRUG DISCOV：耳聋治疗药物进入临床试验

2017-09-04

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Clin Cancer Drugs：靶向特殊通路或可有效治疗前列腺癌

2017-05-10

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Saf：妊娠期母亲药物暴露对新生儿的影响：戒断反应和残余药效

2017-01-06

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

International Journal of Drug Policy：通过经济激励措施推动烟草行业变革

2016-08-14

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：第二代抗精神病药物的肺炎风险对比

2015-11-10

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：FDA和EMA重点审查药品批准的差异性

2015-09-15

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Invest New Drugs：dacomitinib(pan-HER 抑制剂)用于晚期头颈部鳞状细胞癌的药代动力学评价

2015-09-22

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Des Devel Ther：来曲唑结合促性腺激素适合克罗米芬(CC)抵抗的多囊卵巢生育障碍患者

2016-11-08

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Am J Cardiovasc Drugs：长期抗高血压治疗与卒中预防：荟萃分析

2016-01-12

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Nature Reviews Drug Discovery：药商面临巨大挑战：如何提高研发产能？

2016-01-13

科室
- - 订阅+
  - 更多科室
工具
服务